---

Parkinson's Disease - Complete Clinical Review

---

1. Anatomy Relevant to Parkinson's Disease

The Basal Ganglia Circuit

• Pars compacta (SNpc): contains melanin-pigmented dopaminergic neurons that project to the striatum via the nigrostriatal pathway - this is the primary site of neurodegeneration in PD
• Pars reticulata (SNpr): a GABAergic output nucleus of the basal ganglia

• Direct pathway: striatum → GPi/SNpr → thalamus → cortex (facilitatory; uses D1 receptors, activated by dopamine)
• Indirect pathway: striatum → GPe → subthalamic nucleus (STN) → GPi/SNpr → thalamus → cortex (inhibitory; uses D2 receptors, inhibited by dopamine)

• Olfactory bulb and enteric nervous system (early; stages 1-2)
• Locus coeruleus, dorsal raphe, dorsal motor nucleus of vagus (stages 1-2)
• Substantia nigra and basal forebrain (stages 3-4 - symptomatic phase)
• Limbic cortex, neocortex (late stages 5-6)

---

2. Types of Parkinson's Disease

A. Idiopathic (Primary) Parkinson's Disease

B. Genetic Forms of PD

---

3. Positive Findings in Parkinson's Disease

Cardinal Motor Signs (TRAP)

• Characteristic 4-6 Hz "pill-rolling" rest tremor
• Appears when limb is fully at rest; disappears with voluntary movement
• Asymmetric onset (typically one hand)
• Re-emergent postural tremor (appears after a latency of a few seconds when arms are outstretched)

• Velocity-independent lead-pipe resistance to passive movement
• Cogwheel rigidity: tremor superimposed on rigidity, gives a ratchet-like quality
• Present at wrist, elbow, neck; tested by passive joint movement
• Froment's maneuver (contralateral voluntary movement amplifies rigidity on the tested side - positive finding)

• Slowness of movement (bradykinesia) with progressive decrement in speed and amplitude on repetitive movements
• Assessed by finger tapping, hand opening/closing, foot tapping
• Hypomimia: masked/poker face, reduced blinking (2-10/min vs normal 12-20/min)
• Hypophonia: soft, monotone voice
• Micrographia: progressively smaller handwriting
• Hypodiadochokinesia: impaired rapid alternating movements

• Pull test (Retropulsion test): examiner pulls patient backward by shoulders; patient fails to take a corrective step or falls - strongly positive in PD
• Usually a late feature (if early, suggests atypical parkinsonism)

Other Positive Clinical Findings

• Festination: shuffling gait with short steps, accelerating to keep up with shifted centre of gravity
• Reduced arm swing (often unilateral early)
• Freezing of gait (FOG): sudden inability to initiate or continue walking
• Camptocormia: abnormal forward flexion of thoracolumbar spine

• Procerus sign (furrowing between brows): more typical of PSP; PD shows hypomimia instead
• Seborrhoeic dermatitis over face

• Orthostatic hypotension
• Constipation (often precedes motor symptoms by years)
• Urinary dysfunction
• Hyperhidrosis
• Sialorrhoea (drooling)

• Hyposmia/anosmia (often precedes motor symptoms; one of earliest markers)
• REM Sleep Behavior Disorder (RBD): acting out dreams; a major prodromal feature
• Depression and anxiety
• Cognitive impairment / dementia (Parkinson's disease dementia, PDD)
• Visual hallucinations (later stage)
• Pain and sensory symptoms

---

4. PG Level Assessment (Prognostic Grading / Clinical Scales)

A. Hoehn and Yahr Scale (H&Y)

B. MDS-UPDRS (Movement Disorder Society - Unified Parkinson's Disease Rating Scale)

C. Mini-Mental State / MoCA

D. Schwab & England ADL Scale

---

5. Pathology of Parkinson's Disease

Macroscopic Pathology

• Depigmentation of the substantia nigra: loss of melanin-containing neurons causes visible pallor of the SN in cross-sections of the midbrain (compared to the normal dark appearance)
• Pallor also seen in the locus coeruleus

Microscopic Pathology

• Selective loss of dopaminergic neurons in the SNpc (60-80% lost before symptoms appear)
• Remaining neurons show degenerative changes

• Intraneuronal, round, eosinophilic cytoplasmic inclusions with a pale halo
• On H&E: dense core (eosinophilic, 5-25 µm) surrounded by a clear halo, displacing neuromelanin
• Composed of: α-synuclein (major protein), ubiquitin, neurofilaments, proteasome components
• On α-synuclein immunostaining: stain intensely red/brown
• Found in SNpc, locus coeruleus, dorsal vagal nucleus, cortex (in PDD)

• Abnormal, dystrophic neuritic processes containing α-synuclein aggregates
• Found in the CA2/3 region of the hippocampus and elsewhere

• Astrocytic gliosis in areas of neuronal loss

Braak Staging of PD Pathology

Neurochemical Pathology

---

6. Parkinson's Disease vs. Parkinsonism - Key Differences

Causes of Parkinsonism (Non-PD)

---

7. Diagnostic Criteria Summary (MDS Clinical Criteria)

1. Absence of absolute exclusion criteria
2. At least two supportive criteria
3. No red flags

• Unilateral onset
• Clear and dramatic response to levodopa (70-100%)
• Levodopa-induced dyskinesia
• Rest tremor
• Hyposmia or loss of smell
• Cardiac sympathetic denervation on MIBG scintigraphy
• Presence of Lewy bodies on biopsy (definitive)

• Unequivocal cerebellar features
• Downward vertical supranuclear gaze palsy
• Frontotemporal dementia within first 5 years
• Purely lower-limb parkinsonism for >3 years
• No response to levodopa despite adequate dose
• Cortical sensory loss, alien limb

---

Recent Evidence Note

---

• Bradley and Daroff's Neurology in Clinical Practice (9780323642613)
• Adams and Victor's Principles of Neurology, 12th Edition (9781264264520)
• Harrison's Principles of Internal Medicine 22E (9781265977061)
• MDS Clinical Diagnostic Criteria for Parkinson's Disease (Postuma et al., 2015)

Parkinsonism: Types, Clinical Diagnosis & Management

---

PART 1 - TYPES IN DETAIL

---

TYPE 1: Idiopathic Parkinson's Disease (Primary PD)

Overview

Subtypes by Motor Phenotype

Clinical Diagnosis

• Unilateral/asymmetric onset
• Classic 4-6 Hz pill-rolling rest tremor
• Clear, dramatic response to levodopa (70-100%)
• Levodopa-induced dyskinesia
• Hyposmia/anosmia
• Positive cardiac MIBG scintigraphy
• REM sleep behavior disorder (prodromal)

• Rapid progression to wheelchair in <3 years
• Absence of levodopa response despite adequate dose
• Early bulbar dysfunction
• Early severe autonomic failure
• Early falls (within 3 years)
• Inspiratory sighs, stridor
• Symmetric parkinsonism at onset

• MRI brain: usually NORMAL (important to exclude structural causes)
• DAT-SPECT/PET: asymmetrically reduced dopamine transporter uptake in putamen
• MIBG cardiac scintigraphy: reduced cardiac sympathetic uptake (supports PD over MSA/PSP)
• α-synuclein seed amplification assay (CSF/skin): emerging biomarker (high sensitivity/specificity per 2025 meta-analysis, PMID 41324773)

---

TYPE 2: Progressive Supranuclear Palsy (PSP) - Tauopathy

Overview

Clinical Phenotypes (MDS Criteria 2017)

How to Diagnose Clinically

• Vertical supranuclear gaze palsy (VSGP): inability to voluntarily look up or (especially) down - HIGH SPECIFICITY
• Slowed vertical saccades (earliest sign - use "doll's head" maneuver to distinguish supranuclear)
• "Square wave jerks" on examination
• Reduced blink rate
• "Procerus sign": deep furrowing between brows giving an astonished/angry look

• Falls BACKWARD (retrocollis, extension posture - opposite to PD's forward stoop)
• Early falls within 1-2 years of onset (HIGH SPECIFICITY for PSP)
• Broad-based gait with truncal extension ("soldier's gait")
• Positive pull test: falls without attempting to correct

• Symmetric, predominantly axial rigidity (neck and trunk > limbs)
• Nuchal rigidity/retrocollis
• Dysarthria: hypophonic, spastic or mixed quality
• Dysphagia with risk of aspiration

• Frontal executive dysfunction (disinhibition, impulsivity, apathy)
• Pseudobulbar affect (emotional lability, forced crying/laughing)
• Bradyphrenia (slow thinking)

• MRI brain (sagittal T1): "Hummingbird sign" (midbrain atrophy on midsagittal view) + "Morning Glory" sign on axial view (superior cerebellar peduncle atrophy)
• Midbrain/pons ratio <0.52 on MRI (Magnetic Resonance Parkinsonism Index)
• DAT-SPECT: reduced but symmetrically
• CSF: elevated total tau (non-specific)
• Levodopa response: poor or absent

---

TYPE 3: Multiple System Atrophy (MSA) - Synucleinopathy

Overview

How to Diagnose Clinically

• Orthostatic hypotension: BP drop ≥30 mmHg systolic or ≥15 mmHg diastolic on standing
• Urinary incontinence or incomplete bladder emptying (postvoid residual >100 mL)
• Erectile dysfunction in males (often first symptom)

• Bradykinesia + rigidity
• Minimal/absent resting tremor (unlike PD)
• Anterocollis (neck flexed forward) - characteristic
• "Jerky" postural tremor sometimes present
• Poor/transient levodopa response

• Gait ataxia, limb ataxia
• Cerebellar dysarthria
• Cerebellar oculomotor signs (gaze-evoked nystagmus)

• Stridor (inspiratory - due to vocal cord paresis; can be life-threatening during sleep)
• Cold/discoloured hands ("cold hands sign")
• Camptocormia (extreme forward flexion)
• Pisa syndrome (lateral trunk flexion)
• REM sleep behavior disorder (common)
• Orofacial dystonia

• Early dementia (dementia is unusual in MSA; its presence suggests DLB or PSP)
• Classic pill-rolling rest tremor
• Good sustained levodopa response (>5 years)

• MRI brain:
  • MSA-P: putaminal atrophy; T2 hypointensity of posterior putamen; T2 hyperintensity of lateral putaminal rim ("putaminal rim sign")
  • MSA-C: pontine/middle cerebellar peduncle atrophy; "hot cross bun sign" (T2 cross-shaped hyperintensity in pons) - HIGHLY characteristic
• Autonomic reflex screen: orthostatic BP drop + anhidrosis pattern
• Thermoregulatory sweat testing: central pattern anhidrosis
• Postvoid residual >100 mL (urodynamic)
• Sphincter EMG: denervation in external anal/urethral sphincter (supports MSA)

---

TYPE 4: Corticobasal Degeneration (CBD) / Corticobasal Syndrome (CBS) - Tauopathy

Overview

• CBD = pathological diagnosis (confirmed at autopsy)
• CBS = clinical syndrome (multiple pathologies can cause it: CBD, PSP, AD)

Clinical Phenotypes

How to Diagnose Clinically

• Rigidity, dystonia, and bradykinesia dramatically worse on ONE side

• The affected limb acts involuntarily, feels foreign to the patient
• "My hand moves on its own" or "tries to choke me"
• Most common in the arm contralateral to more atrophic hemisphere

• Astereognosis (inability to identify objects by touch)
• Graphesthesia impairment
• Extinction on double simultaneous stimulation

• Limb-kinetic apraxia (inability to perform skilled movements)
• Ideomotor apraxia
• Tested by asking patient to imitate gestures or perform object use

• Action-induced, stimulus-sensitive myoclonus (sudden jerks)
• Can look like tremor but jerky/irregular quality

• Fixed posturing of affected hand/arm
• "Striatal hand" deformity

• Cognitive/behavioral changes (late)
• Supranuclear gaze palsy (may overlap with PSP)
• Speech: nonfluent, apraxia of speech

• MRI brain: Asymmetric frontoparietal atrophy (contralateral to more affected limb)
• FDG-PET: asymmetric frontoparietal hypometabolism
• DAT-SPECT: asymmetrically reduced, worse on the side contralateral to motor symptoms
• CSF: elevated total tau (similar to PSP)
• Levodopa response: absent

---

TYPE 5: Dementia with Lewy Bodies (DLB) - Synucleinopathy

Overview

How to Diagnose Clinically (McKeith DLB Criteria 2017)

• Day-to-day variation in alertness and attention
• Sudden confusional episodes; prolonged staring spells
• Periods of inappropriate drowsiness

• Typically vivid, detailed (people, animals)
• Early in course, even in clear consciousness
• A "sense of presence" (paranormal perception) may precede hallucinations

• Acting out vivid dreams (kicking, punching)
• Often precedes dementia by years
• Confirmed by polysomnography (loss of REM atonia)

• Bradykinesia, rigidity, gait disturbance
• Less asymmetric than PD
• Resting tremor less prominent

• Severe neuroleptic sensitivity (antipsychotics cause dangerous reactions - MUST AVOID typical antipsychotics)
• Repeated falls and syncope
• Severe autonomic dysfunction (orthostatic hypotension, constipation)
• Hypersomnia
• Hyposmia
• Delusions (Capgras syndrome - believing loved ones replaced by impostors)
• Depression

• Reduced dopamine transporter on SPECT/PET (DAT-SPECT)
• Reduced cardiac MIBG uptake
• Polysomnographic confirmation of RBD
• Low Aβ42 on CSF (amyloid co-pathology common)

---

TYPE 6: Drug-Induced Parkinsonism (DIP)

Overview

• Antipsychotics (D2 blockers): haloperidol, chlorpromazine
• Atypical antipsychotics: risperidone, olanzapine (less but still possible)
• Antiemetics: metoclopramide, prochlorperazine
• Calcium channel blockers: flunarizine, cinnarizine
• Reserpine, tetrabenazine

How to Diagnose Clinically

• Temporal relationship to offending drug (onset usually within weeks of starting drug)
• Bilateral, symmetric parkinsonism (not asymmetric like PD)
• Drug-induced akathisia often co-present
• Rabbit syndrome (perioral tremor) is specific to drug-induced
• Improvement/resolution after drug withdrawal (weeks to months)
• DAT-SPECT: NORMAL (unlike PD where DAT is reduced) - this is the key distinguishing test

---

TYPE 7: Vascular Parkinsonism (VP)

Overview

How to Diagnose Clinically

• Lower body predominance (gait disorder, "lower half parkinsonism") - legs most affected, arms relatively spared
• Marche à petits pas: small-stepped shuffling gait without arm involvement
• Upper body relatively unaffected (no upper limb tremor/rigidity early)
• Pyramidal signs co-existing (hyperreflexia, Babinski sign)
• Pseudobulbar palsy (dysarthria, dysphagia, forced laughter/crying)
• No rest tremor (or minimal)
• Sudden onset or stepwise deterioration (corresponds to new strokes)
• Poor levodopa response
• Cognitive impairment/dementia common

• MRI brain: periventricular white matter lesions, lacunar infarcts in basal ganglia/internal capsule, ventricular dilatation
• DAT-SPECT: may be normal OR show homogeneous symmetric reduction (unlike asymmetric PD)

---

PART 2 - SHORT-TERM AND LONG-TERM GOALS

Short-Term Goals (Weeks to Months)

Long-Term Goals (Months to Years)

---

PART 3 - MANAGEMENT

A. Idiopathic Parkinson's Disease - Pharmacological

Stage-Based Algorithm

NEWLY DIAGNOSED PD
        |
        ↓
Is treatment needed (functional impairment)?
    No → Observe, exercise, education
    Yes → Choose initial therapy based on age
        |
    Age <70, no cognitive issues → Dopamine Agonist (DA) or MAO-B inhibitor
    Age >70 or cognitive issues → Start Levodopa/Carbidopa

Drug Classes and Mechanisms

Managing Motor Complications

• Shorten levodopa dosing interval
• Add COMT inhibitor (entacapone)
• Add MAO-B inhibitor
• Switch to extended-release levodopa/carbidopa/entacapone
• Apomorphine SC injections (rescue)
• Continuous subcutaneous apomorphine infusion
• Levodopa-carbidopa intestinal gel (LCIG/Duodopa pump) - for advanced disease

• Reduce individual levodopa dose; increase frequency
• Add amantadine (ER formulation)
• GPi-DBS (better dyskinesia control than STN-DBS)

• Levodopa optimisation (freezing in OFF state)
• Visual cues (stripes on floor), auditory rhythmic cues
• Treadmill training, physiotherapy

Surgical Management

• Disabling motor fluctuations despite optimised pharmacotherapy
• Levodopa-responsive symptoms
• Duration of disease typically >4-5 years

---

B. Management - Clinical Feature-Wise

1. Tremor

• Levodopa (good response)
• Dopamine agonists
• Propranolol (adjunct for action tremor)
• Anticholinergics (young patients; use cautiously)
• Thalamic DBS/FUS (severe refractory tremor)

2. Rigidity and Bradykinesia

• Levodopa/carbidopa (most effective)
• Dopamine agonists
• MAO-B inhibitors
• Physiotherapy: rhythmic, repetitive active exercises

3. Postural Instability and Gait

• Physiotherapy (balance training, gait retraining)
• Auditory cueing (metronome/rhythmic cues) - 2024 Cochrane meta-analysis (PMID 38588457) confirms exercise significantly improves walking and balance
• Nordic walking, treadmill training
• Occupational therapy for fall prevention
• Fludrocortisone (if orthostatic hypotension worsening gait)
• Botulinum toxin for focal dystonia causing gait problems
• Deep brain stimulation (STN or GPi)

4. Speech (Hypophonia)

• Lee Silverman Voice Treatment (LSVT LOUD): high-effort voice training; most evidence-based
• Speech-language therapy
• Amplification devices

5. Dysphagia

• Modified barium swallow / FEES for assessment
• Speech-language therapy: swallowing exercises, dietary modifications (thickened fluids)
• Upright posture during meals; chin-tuck maneuver
• PEG tube (late-stage, severe dysphagia)
• Levodopa timing to optimise swallowing before meals

6. Non-Motor Symptoms

---

C. Management of Atypical Parkinsonism

---

D. Non-Pharmacological Management (All Types)

Physiotherapy

• Balance retraining, cueing strategies (visual floor stripes, auditory rhythmic cues)
• Nordic walking, treadmill training, resistance training
• 2024 Cochrane network meta-analysis (PMID 38588457): exercise is the most evidence-based non-pharmacological intervention for motor symptoms in PD; dance and tai chi show particularly strong balance benefits

Occupational Therapy

• ADL retraining and assistive devices
• Home safety assessment
• Handwriting aids; utensil modifications

Speech-Language Therapy

• LSVT LOUD (hypophonia)
• Lee Silverman Voice Treatment BIG (bradykinesia and small movements)
• Dysphagia management

Multidisciplinary Team (MDT) - Core Members

• Neurologist/movement disorder specialist
• Physiotherapist
• Occupational therapist
• Speech and language therapist
• Parkinson's disease nurse specialist
• Dietitian
• Psychologist/Psychiatrist
• Palliative care (advanced disease)
• Social worker

Exercise (Strong Evidence)

• Aerobic exercise, resistance training, dance, tai chi, yoga all benefit motor symptoms and quality of life
• Recommended: minimum 150 minutes moderate-intensity exercise per week
• Exercise may have neuroprotective effects (PMID 38588457, 39880702)

---

E. Late-Stage / Palliative Care Goals

• Comfort and dignity as the primary focus
• Management of aspiration pneumonia (most common cause of death)
• Pain management
• PEG feeding decisions
• Advance care planning
• Psychological support for patient and carers
• Hospice referral when appropriate

---

• Bradley and Daroff's Neurology in Clinical Practice (9780323642613)
• Adams and Victor's Principles of Neurology, 12th Ed. (9781264264520)
• Gilman et al. 2008 MSA Consensus Criteria
• MDS Clinical Diagnostic Criteria for PSP (2017)
• Practical Neurology: Diagnosis and Management of Neurodegenerative Atypical Parkinsonism
• Cochrane meta-analysis on exercise in PD (PMID 38588457, 2024)Here is a summary of what was covered:

---

What Was Covered

Part 1 - Types in Detail (7 types)

1. Idiopathic PD - with 4 motor subtypes (Tremor-dominant, Akinetic-Rigid, PIGD, Young-onset)
2. PSP - 5 phenotypes, MDS OPAC diagnostic framework, hummingbird sign
3. MSA - MSA-P vs MSA-C, autonomic criteria, hot cross bun sign
4. CBD/CBS - alien limb, asymmetric rigidity, apraxia, cortical sensory loss
5. DLB - McKeith criteria, fluctuating cognition, RBD, neuroleptic sensitivity
6. Drug-Induced Parkinsonism - symmetric, reversible, normal DAT scan
7. Vascular Parkinsonism - lower body predominance, pyramidal signs, MRI white matter changes

Part 2 - Goals

• Short-term: motor control, fall prevention, ADL independence, dysphagia screening, education
• Long-term: delay motor complications, manage dementia/autonomic/psychiatric features, DBS candidacy, advance care planning

Part 3 - Management

• Drug-wise: Levodopa, DAs, MAO-B inhibitors, COMT inhibitors, Amantadine, Anticholinergics - each with mechanism, indication, and when to use
• Feature-wise: tremor, rigidity, gait/freezing, speech, dysphagia, depression, psychosis, RBD, constipation, orthostatic hypotension
• Atypical types: individual management tables for PSP, MSA, CBD, DLB, DIP, Vascular
• Non-pharmacological: MDT roles, exercise evidence (2024 Cochrane), LSVT, PT/OT/SLT
• Palliative: late-stage goals including aspiration management and advance care planning

---

Physiotherapy Management of Parkinson's Disease

---

Overview and Rationale

---

Physiotherapy Assessment Framework

---

Physiotherapy Goals

Short-Term Goals (4-12 weeks)

Long-Term Goals (Months to Years)

---

Core Physiotherapy Interventions

---

1. Gait Training

A. Treadmill Training

• One of the most well-studied interventions
• Body-Weight Supported Treadmill Training (BWS-TT): rated highest for improving overall balance scores (BBS p-score 0.97) and dynamic steady-state balance in a 2023 network meta-analysis of 24 exercise types (PMID 37641007)
• Provides a rhythmic, forced pace that bypasses the basal ganglia deficit
• Improves walking speed, stride length, endurance
• Protocol: typically 3x/week, 20-30 min sessions, moderate intensity

B. Overground Gait Training

• Focus on attentional strategies: "big steps," "high steps," "swing arms"
• Lee Silverman Voice Treatment BIG (LSVT BIG): translates the amplitude-focused LSVT principle to whole-body movements - patients trained to take LARGE movements; improves gait and motor function

C. Cueing Strategies

D. Freezing of Gait (FOG) Strategies

• Mental imagery before stepping: visualise a large stride before moving
• Step-over obstacle: laser pointer on walking frame; stepping over imaginary line
• Counting or marching in place before initiating
• Shifting weight: rock side to side to initiate stepping
• Backward walking: can paradoxically unfreeze some patients
• Environmental modifications: remove rugs, clutter; widen doorways; avoid narrow spaces

---

2. Balance Training

A. Static Balance Exercises

• Narrow base of support standing (feet together)
• Single-leg stance (with support as needed)
• Tandem standing
• Standing on foam/unstable surface (proprioceptive challenge)

B. Dynamic Balance Exercises

• Weight shifting: side-to-side and forward-backward
• Stepping in all directions
• Reaching tasks (moving centre of gravity outside base of support)
• Functional reach training

C. Reactive Balance / Perturbation Training

• Therapist applies unexpected perturbations to the patient while standing
• Patient practices rapid stepping responses
• Evidence suggests reactive balance training specifically reduces fall frequency
• BGT-ECA (Balance and Gait Training with External Cue or Attention) - top ranked for reactive balance (PMID 37641007)

D. Dual-Task Training

• PD patients are highly susceptible to dual-task interference (walking + talking = falls)
• Training: practice balance/walking while performing cognitive tasks (counting backwards, carrying a tray)
• Gradually progress cognitive challenge
• Motor-cognitive dual-task training improves both gait and cognition

E. Technology-Assisted Balance

• Wii Fit / Balance Board: visual biofeedback of centre of pressure; engaging and motivating
• Robotic-assisted gait and balance (RA-GT): top-ranked for reactive balance (PMID 37641007)
• Virtual reality (VR): immersive environments for obstacle avoidance, balance challenges

---

3. Strengthening Exercises

• Lower limb strengthening: squats, sit-to-stand, step-ups, leg press, calf raises
• Trunk stabilisation: core exercises (bridges, dead bug, bird-dog), particularly important for camptocormia/Pisa syndrome
• Upper limb: shoulder external rotation, rowing exercises (counteract the flexed stooped posture)
• Resistance training: 2024 Cochrane (PMID 38588457) - small but meaningful improvement in UPDRS motor scores (MD -4.96 vs passive control)
• Frequency: 2-3x/week; 2-3 sets of 8-15 repetitions; progressive overload

---

4. Flexibility and Stretching

• Active and passive ROM exercises for all major joints
• Trunk rotation exercises: rotational movements in lying, sitting, standing
• Chest wall stretches: doorway stretches, thoracic extension over foam roller
• Hip flexor stretches: lunge position
• Postural correction: shoulder retraction, scapular squeezes, chin tucks
• Yoga: systematic review evidence supports yoga for rigidity, flexibility, and quality of life in PD
• Timing: best performed during medication "on" phase when rigidity is reduced

---

5. Postural Training

• Thoracic extension exercises over foam roller
• Wall standing: standing with back against wall; practice maintaining upright posture
• Mirror feedback: patient observes and corrects posture in mirror
• Taping techniques: kinesiotaping to facilitate erect posture
• McKenzie extension exercises (adapted)
• Scapular stabilisation program
• Body awareness training: Feldenkrais, Alexander Technique
• For severe camptocormia: thoracolumbar orthosis (TLSO) as adjunct

---

6. Transfers and Functional Mobility

Sit-to-Stand

• Move to edge of seat first
• Feet hip-width apart, tuck feet under chair
• Lean forward ("nose over toes")
• Push through arms and legs simultaneously
• Verbal counting cue to initiate ("1-2-3-up")
• Chair height modifications (raised seat cushion)

Bed Mobility

• Log roll technique: bend knees, arms crossed, roll to side
• Push up to sitting from side-lying
• Satin/silk sheets to reduce friction during turning in bed
• Bed rails or rope ladder if needed

Floor Rise

• Essential life skill to address early
• Sequence: roll to side → hands and knees → step one foot up → use chair to push to standing
• Practise regularly; family to be taught also

Car Transfers

• Swivel cushion for car seat
• Grab handles; avoiding low sports car seats

---

7. Aerobic / Cardiovascular Exercise

• Cycling: stationary cycling (including forced-rate cycling at higher cadence than voluntary); improvements in motor symptoms
• Walking programs: regular brisk walking; Nordic walking (poles improve posture and arm swing)
• Swimming: aquatic exercise - ranked highly for static balance (sSSB, p-score 0.85; PMID 37641007); water buoyancy reduces fall risk, allows larger movements
• Dance: strongest evidence for motor signs in 2024 Cochrane NMA - UPDRS-M MD -10.18 (dance ranked FIRST; moderate confidence); tango has most evidence among dance forms; Irish set dancing, ballroom also studied
• Tai Chi: high-quality evidence for balance and fall reduction; improves reactive balance; accessible and enjoyable
• Target: ≥150 minutes/week moderate-intensity aerobic activity (WHO/NICE recommendation)

---

8. Respiratory Physiotherapy

• Diaphragmatic breathing exercises: deep belly breathing; pursed lip breathing
• Inspiratory muscle training (IMT): threshold device (eg Threshold IMT); improves inspiratory muscle strength
• Active cycle of breathing technique (ACBT): for secretion clearance
• Thoracic mobility exercises: rotational and lateral flexion
• Postural drainage (if secretions present)
• Huffing and assisted cough: important in late-stage disease

---

9. Aquatic Physiotherapy (Hydrotherapy)

• Warm water (34-36°C) reduces rigidity and facilitates movement
• Buoyancy support allows balance training with reduced fall risk
• Hydrostatic pressure assists proprioception
• Exercises: walking in water, stepping, balance challenges, rotation, swimming
• Aquatic exercise ranked top for improving static steady-state balance (PMID 37641007)
• Particularly useful for patients with severe postural instability or fear of falling

---

10. Mind-Body Therapies

---

11. Home Exercise Programme (HEP)

• 2023 meta-analysis (PMID 38114897): home-based exercise improves motor symptoms, quality of life, and functional performance significantly vs control
• Components: stretching, strengthening, balance, walking, breathing
• Frequency: daily practice preferred; minimum 5 days/week
• Technology: smartphone apps (Parkinson's Exercise: PD Warrior), YouTube programs, Nintendo Wii/games
• Caregiver involvement in monitoring and assistance
• Review and progress every 4-8 weeks

---

Stage-Based Physiotherapy Approach

---

Assistive Devices and Equipment

---

Physiotherapy in Atypical Parkinsonism

---

Multidisciplinary Integration

• Physiotherapy + Speech-Language Therapy (LSVT LOUD for voice; LSVT BIG for movement - these are linked programmes)
• Physiotherapy + Occupational Therapy (ADL integration of movement gains)
• Physiotherapy + Neurologist (timing PT sessions in medication "on" phase for maximum benefit)
• Physiotherapy + Dietitian (nutritional support for exercise; weight management)
• ParkinsonNet model (Netherlands): specialist PT network trained specifically in PD - associated with better outcomes and lower healthcare costs

---

Evidence Summary Table

---

Key Clinical Tips for Physiotherapists

1. Time sessions during medication "on" phase - typically 45-90 minutes after levodopa dose; motor performance is significantly better during "on"
2. Start early - physiotherapy in early PD has better long-term outcomes than starting late; neuroprotective exercise principles apply
3. High intensity when possible - forced-rate exercise (cycling at cadence above voluntary maximum) shows particular benefit; intensity appears important
4. Progress the programme - static → dynamic → dual-task → perturbation; continue adding challenge
5. Group sessions - peer motivation; social engagement; cost-effective; evidence supports group exercise formats
6. Avoid over-fatigue - PD patients tire easily; balance effort with rest; monitor for medication wearing-off during sessions
7. Educate family and carers - cueing strategies, transfer assistance, fall response should be taught to carers
8. Fear of falling is common and disabling - address psychological component alongside physical; graded exposure to challenging situations

---

• Adams and Victor's Principles of Neurology, 12th Edition
• European Physiotherapy Guideline for Parkinson's Disease (ParkinsonNet, 2014 - still primary reference)
• ANPT Clinical Practice Guideline for Physical Therapist Management of Parkinson Disease (2022)
• Cochrane NMA on Exercise in PD (PMID 38588457, 2024)
• Network meta-analysis of 24 exercise types (PMID 37641007, 2023)
• Auditory cueing systematic review (PMID 38897907, 2024)
• npj Parkinson's Disease balance physiotherapy dose-response meta-analysis (2026)